Search Results
49 Results for 'Diagnostics & Biomarkers'
PAGE 2 OF 2
Technology
Unbiased Dna Methylation Markers Define An Extensive Field Defect In Histologically Normal Prostate Tissues Associated With Prostate Cancer: New Biomarkers For Men With Prostate Cancer
A method of detecting the presence of a prostate cancer field defect in a human subject comprising the step of (a) obtaining genomic DNA from the human subject and (b) quantitating methylation in at l...
Learn More
Learn More
David Jarrard, Bing Yang | P170024US02
Technology
Epithelial Quantitation Of Histologically Normal Prostate Tissue Predicts The Presence Of Cancer In Tissue Biopsies
A method of detecting the presence of a prostate cancer in a human subject comprising the steps of (a) obtaining a histologically normal prostate tissue sample from the patient and (b) quantifying the...
Learn More
Learn More
David Jarrard, Bing Yang | P170023US02
Technology
Bystander Immune Suppression As A Predictor For Response To A Vaccine
The present invention relates to antigen-specific immune regulatory response. Methods for detecting an antigen-specific immune regulatory response, methods for selecting candidate vaccine recipients, ...
Learn More
Learn More
Douglas McNeel, William Burlingham | P100331US02
Technology
Using Liquid Crystal To Detect Endotoxin In The Presence Of One Or More Potential Masking Agents
Devices and methods for using changes in the configuration of micrometer sized dispersed liquid crystal domains to detect or quantify analytes in a test sample, including endotoxin lipopolysaccharide ...
Learn More
Learn More
Nicholas Abbott, Abhijit Dan | P160072US02
Technology
Nanoengineered Surfaces For Cancer Biomarker Capture
Described herein is cancer biomarker, e.g., a vesicle, capture surface that includes a substrate, a first plurality of nanoparticles attached to the substrate; a plurality of bifunctional tethers, whe...
Learn More
Learn More
Seungpyo Hong, Michael Poellmann | P180105US02
Technology
Antibodies Targeting Glioblastoma Stem-Like Cells And Methods Of Use Thereof
The present invention provides antibodies that target glioblastoma stem-like cells and methods and kits for their use.
Learn More
Learn More
Eric Shusta, Michael Zorniak, Paul Clark, Yongku Cho, Benjamin Umlauf, John Kuo | P180018US02
Technology
Biomarkers For Early Diagnosis And Differentiation Of Mycobacterial Infection
Mycobacterial-specific biomarkers and methods of using such biomarkers for diagnosis of mycobacterial infection in a mammal are disclosed.
Learn More
Learn More
Adel Talaat, Chia-Wei Wu | P190048US02
Technology
Multicolor Reporter Cells for Detecting and Quantifying HIV-1
It is estimated that half of new HIV infections in the U.S. are from patients who know they are HIV-positive but underestimate their transmissibility. Identifying and monitoring the latent HIV reservo...
Learn More
Learn More
Nathan Sherer, Jordan Becker | P160337US02
Technology
Blood Protein Biomarkers for Detection of Colon Cancer
Colorectal cancer is a major cause of cancer-related morbidity and mortality in developed nations, causing more than 600,000 deaths worldwide every year. While early detection of localized colorectal ...
Learn More
Learn More
Michael Sussman, William Dove, Melanie Ivancic, Jennifer Pleiman, Edward Huttlin, Perry Pickhardt, Xiaodi Chen, Amy Irving, Adrian Hegeman, Mark Reichelderfer, Gregory Kennedy | P150077US02
Technology
Biomarkers For Breast Cancer And Methods Of Use Thereof
Advances in screening and detection have led to an increase in the diagnosis of early stage breast cancer. Plotting the optimal course of treatment (i.e., more or less aggressive) remains a challenge,...
Learn More
Learn More
James Shull | P160213US02
Technology
Enhanced Endotoxin Detection: New Advantages in Liquid Crystal Assays for Gram-Negative Pathogens
Gram-negative bacterial infections are an ongoing challenge to health care providers worldwide. Detection, treatment and control of such pathogens have gained increasing importance in the context of a...
Learn More
Learn More
Nicholas Abbott, Abhijit Dan | P160072WO01
Technology
Field Test for Mycobacterial Infections
Mycobacterial infections cause major health problems for people and animals, including human tuberculosis, bovine tuberculosis and Johne’s disease. Johne’s disease (or paratuberculosis) afflicts 9...
Learn More
Learn More
Adel Talaat | P150020US02
Technology
Assay to Determine Risk of Fungal Infection
Fungal infections such as aspergillosis and Valley Fever can be life threatening, particularly in immune-compromised patients. These patients are vulnerable to fungal strains that flourish in hospital...
Learn More
Learn More
Bruce Klein, Marcel Wuethrich | P140236US02
Technology
Biomarkers for Detecting Prostate Cancer
Prostate cancer is the second most common cancer in American men, causing more than 27,000 deaths every year. An estimated one man in seven will be diagnosed with prostate cancer during his lifetime.E...
Learn More
Learn More
David Jarrard, Bing Yang | P130258US03
Technology
Detecting Ovarian Cancer and Risk
Ovarian cancer is the most fatal gynecological cancer, killing 15,000 women in the Unites States every year. The overall five-year relative survival rate for women with ovarian cancer is 46 percent. T...
Learn More
Learn More
Halcyon Skinner, Gary Schwartz | P130052US03
Technology
Diagnostic Kit for Blastomycosis
Blastomyces dermatitidis is a soil fungus found throughout the world, and is especially prevalent in the river valleys and Great Lakes region of the United States. If spores are inhaled, blastomycosis...
Learn More
Learn More
Bruce Klein, Theodore Brandhorst | P110280US02
Technology
Monoclonal and Polyclonal Antibodies Raised to Recombinant Mengovirus 3D Polymerase
Mengovirus is a picornavirus that causes encephalomyocarditis in humans and other animals.
Learn More
Learn More
Ann Palmenberg, Hernando Duque | P97029US
Technology
Prostate Cancer and Melanoma Screening
Almost 200,000 men in the United States develop prostate cancer each year. More than 60,000 people develop melanoma. Early diagnosis is key to survival because the best treatment and prognosis for the...
Learn More
Learn More
Douglas McNeel, Edward Dunphy, Jason Dubovsky, Luke Hoeppner | P06004US
Technology
Method and Compositions for Detecting Botulinum Neurotoxin
Botulinum neurotoxins produced by Clostridium botulinum are the most potent toxins known. Because of the threat of bio-terrorism, sensitive methods for detecting botulinum neurotoxin are needed; howev...
Learn More
Learn More
Edwin Chapman, Min Dong | P04086US
Technology
hMREII Antiserum for the Detection of DNA Damage
DNA damage occurs in organisms as a result of exposure to environmental chemicals and radiation. Failure to repair this damage can lead to tumor formation and cancer. Although a gene has been found in...
Learn More
Learn More
John H. J. Petrini | P95198US
Technology
Application of NADH Cytochrome B5 Reductase/System for Direct Metabolism of Xenobiotics
The NADH cytochrome b5 reductase/cytochrome b5 system can transfer electrons to other enzymes, including those involved in the metabolism of fatty acids, toxins and drugs. In the past, NADH cytochrome...
Learn More
Learn More
Lauren Trepanier, Jackie Lynn Miller, Sunil Bajad, Joseph Raymond Kurian | P02388US
Technology
Eight Hybridoma Cell Lines Producing Monoclonal Antibodies Against La Crosse Encephalitis Virus
La Crosse virus is an etiologic agent for childhood encephalitis in North America. Structurally, the nucleocapsid of this virus is enclosed by a host-derived lipid envelope holding two virion glycopro...
Learn More
Learn More
Thomas Yuill | P01150US
Technology
Muc16 Bound to Immune Cells Provides an Improved Indicator for Ovarian Cancer and Preeclampsia
Each year, approximately 20,000 American women are diagnosed with ovarian cancer and about 15,000 women die of the disease. The overall five-year relative survival rate for women with ovarian cancer...
Learn More
Learn More
Manish Patankar, Joseph Connor, Jennifer Belisle | P07365US
Technology
Sensitive Assay for Detecting Botulinum Neurotoxin, Neutralizing Antibodies or Inhibitors
Botulinum toxin is used for cosmetic procedures and to treat neurological disorders from spasmodic disorders to chronic pain syndromes. The most widely used form of botulinum toxin is the serotype A...
Learn More
Learn More
Eric Johnson, Sabine Pellett, William Tepp, Gary Borodic, David Beebe, Amy Paguirigan | P07412US